Comparison of Once-Daily versus Twice-Daily Administration of Cefdinir against Typical Bacterial Respiratory Tract Pathogens
AUTOR(ES)
Ross, Gigi H.
FONTE
American Society for Microbiology
RESUMO
In an in vitro pharmacodynamic model, a twice-daily cefdinir dosing regimen was more effective than a once-daily regimen against common bacterial respiratory pathogens in producing 3-log10 killing and preventing the occurrence of regrowth at 24 h. Twice-daily administration is likely the more appropriate cefdinir dosing strategy for the treatment of community-acquired pneumonia.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=90758Documentos Relacionados
- Once-daily versus twice-daily administration of ceftazidime in the preterm infant.
- Once-daily aminoglycoside therapy.
- Bioavailability of Once- and Twice-Daily Regimens of Didanosine in Human Immunodeficiency Virus-Infected Children
- Once-daily ceftriaxone therapy for serious bacterial infections in children.
- Once-daily aminoglycoside therapy: potential ototoxicity.
